Resistance: latest news

Resistance resources

  • Changing HIV treatment

    Talk to your doctor if you are concerned about any side-effects you are experiencing.If you are having problems taking your HIV treatment, it’s important to be honest...

    From: Factsheets

    Information level Level 2
  • Taking your HIV treatment (adherence)

    Taking your medication exactly as prescribed is key to HIV treatment working.As treatment is a long-term commitment, it’s important that your treatment suits your lifestyle.If you find...

    From: Factsheets

    Information level Level 2
  • Drug resistance

    It's important to always take your HIV treatment at the right times and in the right amounts. If you don't, HIV may become drug resistant.When...

    From: The basics

    Information level Level 1
  • An HIV treatment journey

    This illustrated leaflet shows the journey a lot of people go on with HIV treatment. However, each person’s situation is different. Your own circumstances may...

    From: The basics

    Information level Level 1
  • My drugs chart

    My drugs chart provides information on all the anti-HIV drugs currently licensed for use in Europe.Select your chosen drugs and drag them onto the area...

    From: My drugs chart

  • What is drug resistance?

    One of the possible consequences of not taking your HIV treatment properly is that your HIV will develop resistance to anti-HIV drugs. This section of the booklet provides...

    From: Booklets

    Information level Level 2
  • Resistance tests

    Blood tests are available which detect whether the HIV in your body is resistant to any anti-HIV drugs. It's recommended that you have a drug resistance test before...

    From: Booklets

    Information level Level 2
  • Taking your HIV treatment

    This booklet is a starting point for anyone who wants to know about treatment for HIV. It provides basic information about how HIV treatment works...

    From: Booklets

    Information level Level 2
  • Drug resistance

    HIV reproduces in the body very quickly, making billions of new viruses every day by replicating its genetic material. HIV is a retrovirus; retroviruses have an inherently high...

    From: HIV treatments directory

    Information level Level 4

Resistance in your own words

Resistance news from aidsmap

More news

Resistance news selected from other sources

  • Antibody-Based HIV Tx Proves Durable

    The monoclonal antibody HIV drug ibalizumab, designed for patients who've developed severe drug resistance, had long-lasting protection in the 24-week extension phase of a phase III trial, researchers reported here.

    10 October 2017 | MedPage Today
  • HIV drug resistance found in more than half of young children in Africa

    Approximately 54% of young children with HIV surveyed in Africa had resistance to one or more antiretroviral drugs, according to recent data.

    24 August 2017 | Healio
  • A massive second global wave of AIDS is coming — perhaps within the next 10 years

    Three problems are driving the global fight against HIV into a new danger zone. First, new infections increasingly involve forms of the virus that are already resistant to the primary drugs used to treat and prevent HIV infection. Second, the world is fast approaching the limits of manufacturing capacity for anti-HIV first-line drugs, and the ceiling is far lower for second- and third-line treatments. And third, there aren’t sufficient financial resources applied to the AIDS problem now, and signals from major donors — especially the U.S. government — offer a grim future of diminished resources and greater demands on very poor countries to finance their own HIV fights without outside help.

    31 July 2017 | Business Insider
  • WHO urges action against HIV drug resistance threat

    WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if early and effective action is not taken.

    20 July 2017 | World Health Organization
  • Oral sex spreading unstoppable bacteria

    Oral sex is producing dangerous gonorrhoea and a decline in condom use is helping it to spread, the World Health Organization has said. Gonorrhoea can infect the genitals, rectum and throat, but it is the last that is most concerning health officials. Dr Wi said antibiotics could lead to bacteria in the back of the throat, including relatives of gonorrhoea, developing resistance. She said: "When you use antibiotics to treat infections like a normal sore throat, this mixes with the Neisseria species in your throat and this results in resistance."

    07 July 2017 | BBC
  • Experts raise concerns over high HIV treatment failure in Kenya

    Local and international health authorities are concerned about emerging evidence of high HIV treatment failure in Kenya. The latest findings in a report by the Ministry of Health and the UN published last week spoke of "unacceptably" high failure rates of Anti-retrovirals (ARVs) among refugees and residents of Kakuma in northern Kenya.

    06 June 2017 | The Standard
  • Stock market models accurately predict changes in HIV over time

    Stock market models accurately predict changes in HIV over timeHealioMathematical models that were originally developed to predict changes in stock prices accurately predicted changes in the properties of HIV, suggesting that such models could be used for the development of a future vaccine for HIV, according to data published in PLOS Biology.

    18 May 2017 | Healio
  • Orphan Drug Designation for CytoDyn's PRO 140 Declined by the FDA

    Cytodyn has announced that its application for Orphan Drug Designation (ODD) for PRO 140 was not granted by the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) because PRO 140 appears to have the potential to treat more than just the subset of multi-drug resistant HIV patients for which the designation was requested.

    18 April 2017 | Cytodyn press release
  • Case Report of PrEP Failure: What Can We Learn From It?

    The New England Journal of Medicine has published the first well-documented case of HIV pre-exposure prophylaxis (PrEP) failure despite good medication adherence. We heard lots of this information at CROI last year, and again I'm impressed at the extraordinary degree of virologic investigation done on a case from clinical practice.

    08 February 2017 | The Body Pro
  • The Success Of HIV Treatment Is Increasing The Risk Of Drug-Resistance

    Global health agencies are succeeding in getting more people with HIV on antiretroviral therapy, a combination of drugs that suppress the virus to undetectable levels in the blood and reduce the risk of transmission to another person. But scientists are beginning to detect a disturbing new trend: The rise of drug-resistant HIV strains, especially in countries such as Kenya, Zambia, Uganda, Nigeria, Tanzania and South Africa.

    04 January 2017 | Huffington Post
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.